Treating Chronic Kidney Disease and Causes of Cognitive Impairment with Elizabeth Jeffords and Eva Czirr Alkahest
Manage episode 267225745 series 99915
Elizabeth Jeffords, Chief Commercial and Strategy Officer and Eva Czirr, Associate Director, Alkahest talk about how they are applying their expertise in age-related and neurodegenerative and cognitive diseases to treating chronic kidney disease particularly end stage renal disease. With a focus on cognitive impairment related to inefficient dialysis, Alkahest is decoding the protein beta-2 microglobulin to determine if alleviation of a massive overload of the protein can benefit patients.
@alkahestinc #CKD #ESRD #B2M